The positive inotropic response to angiotensin I and II in cardiac tissue of most mammalian species, as well as the exact site in the heart for conversion of local and systemic angiotensin I into angiotensin II, remains to be elucidated. In isolated cat papillary muscles, angiotensin I and angiotensin 11 (0.1 nM to 1 ,uM, 350 C, 1.25 mM Ca2') increased, in a dose-dependent manner, peak twitch tension with typical slight prolongation of twitch duration. This typical response did not necessitate the presence of an intact endocardial endothelium (EE), as a similar response was observed in muscles where the EE had been damaged by a 1-second exposure to 0.5% Triton X-100. After addition of captopril, an angiotensin converting enzyme inhibitor, the positive inotropic response to angiotensin I was completely abolished, both in the presence and the absence of an intact EE. Hence, the heart possesses angiotensin converting enzyme, which mediates the positive inotropic response to angiotensin I. An intact EE was not a prerequisite for this response; thus, myocytes as well as nonmyocytes may be possible locations (in addition to the EE) for angiotensin converting enzyme. In the presence of an intact EE, and after addition of captopril, the positive inotropic response to angiotensin II was significantly diminished (desensitization). By contrast, in the absence of an intact EE, but also after addition of captopril, the positive response to angiotensin II was potentiated (sensitization). Both desensitization and sensitization (in the presence or absence of an intact EE, respectively) of the response to angiotensin II induced by the addition of captopril were inhibited by indomethacin, a cyclooxygenase inhibitor, suggesting a role for prostaglandins.
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T he positive inotropic and chronotropic effects of angiotensin I and II (Ang l and Ang II) in cardiac tissue of most mammalian species have been well documented.1'-1 These effects have been ascribed to specific receptors localized on cardiomyocytes7,12-17 and on intramyocardial sympathetic nerve terminals,'8-23 but the underlying mechanism of inotropism is as yet only partially understood. Several investigators have demonstrated that the major target organs for Ang II, including the heart,24-27 have independent tissue renin-angiotensin systems and that significant local conversion of Ang I to Ang II by angiotensin converting enzyme (ACE) occurs in cardiac tissue. 18, 24, 26 Locally generated Ang performance of the heart in vivo. However, the exact site in the heart for conversion of locally or systemically generated Ang I into Ang IL is unclear. Endothelial cells in most vascular beds, including the coronary vasculature,28-32 demonstrate potent ACE activity that is directly accessible to circulating blood.
Previous work has shown that endocardial endothelium (EE) can modulate contractile performance of subjacent myocardium in isolated cardiac muscle33'34 and that several substances35-37 exert their inotropic action on the myocardium through the EE. In addition, the EE may be a possible site for ACE,38 hence, for the conversion of local or systemic Ang I into Ang II. We therefore reinvestigated the known inotropic actions of Ang I and Ang II on isolated cardiac muscle in the presence or in the absence of a functional EE.
Materials and Methods

Cardiac Muscle Preparations and Experimental Protocol
Papillary muscles (n=95) were isolated from cat right ventricle (Table 1 ). The muscles were mounted vertically in an organ bath filled with Krebs-Ringer Scale bar, 0.5 pum. Panel D shows that, after Triton X-100 treatment for 1 second, only the plasma membrane at the basal side of the endothelial cells is usually found. Junctional complexes (jc) and cytoskeletal elements (arrowheads) are still present. The basal lamina (arrow), collagen fibers (c), and elastic material (e) have the same ultrastructure as in control muscles. Scale bar, 0.5 pm.
solution and gassed with a 95% 02-5% CO2 mixture. The solution contained (mM) NaCl 118, KCl 4.7, MgSO4* 7H20 1.2, KH2PO4 1.2, CaCl2* 6H20 1.25, NaHCO3 25, and glucose 4.5 at pH 7.4. After a 2-3-hour stabilization period (290 C, 2.5 mM Ca21) at the muscle length at which active force development was maximal (lma,), the actual experiments were performed at 350 C and lm,. Ionized Ca21 in plasma, irrespective of animal species, has been measured between 1 and 1.25 mM39-41; therefore, all experiments were performed at a Ca21 concentration of 1.25 mM.
The lower end of the muscles was held by a phosphor-bronze clip, and the upper tendinous end was connected to an electromagnetic force-length transducer33 with a Tevdek 6.0 braided thread. Muscles were stimulated at 0.2 Hz through a pair of platinum electrodes with a stimulus intensity approximately 10% above threshold. Contractile properties were derived from a preloaded isotonic twitch and an isometric twitch at lmax; maximal velocity of shortening at zero load (Vm.) was obtained by abruptly unloading the stimulated muscle to zero load immediately after the latency period. To eliminate the effect of the muscle's memory for length and load during the preceding twitches, all test twitches were separated by a series of at least eight preloaded isotonic twitches at lmax. Values are mean+SEM and were taken at 350 C and 1.25 mM Ca2+ after 2-3 hours of stabilization before the experiments. EE, endocardial endothelium; n, number of muscles; 1ma muscle length at which active force development was maximal; RT, resting tension at lma,; RT/TT, resting tension/total tension at lma,; MCSA, mean cross-sectional area; TT, peak total twitch tension; Ang I, angiotensin I; Ang II, angiotensin II; PROP, propranolol; PRAZ, prazosin; CAPT, captopril; INDO, indomethacin; +, intact EE at start of angiotensin addition; -, EE damaged before angiotensin addition. Regardless of the presence (+) or absence (-) of EE during the actual experiments, all data in this table are from muscles with intact EE. The RTITT values are slightly higher than in previously published data33,37 due to the different baseline conditions of temperature and calcium concentration.
*For Ang I -EE, nine out of 12 muscles were the same as in Ang I +EE.
tFor Ang II -EE, six out of eight muscles were the same as in Ang II +EE.
Removal of Functional Endocardium
To damage the EE, muscles in their working position were immersed for 1 second in 0.5% Triton X-100 dissolved in Krebs-Ringer solution at 350 C, followed by an abundant wash with Krebs-Ringer solution also at 350 C. Triton X-100 is a nonionic detergent (polyoxyethylene ether). As outlined previously,33 an exposure time of 1 second to Triton followed by abundant wash sufficed to selectively destroy the EE but was only a negligible fraction of the time needed for detergent treatment to damage the subjacent myocardium. The integrity of the myocardium after endocardial damage was indicated by light and electron microscopy (morphologically), by an unchanged maximal contractile performance at high calcium concentrations, and by unaltered Vmax (functionally).
As shown on scanning and transmission electron microscopy in Figure 1 , Triton immersion resulted in characteristic endocardial damage. Control papillary muscles had a perfectly intact EE. For transmission electron microscopy, muscles were fixed in a solution of 2% glutaraldehyde in 0.1 M cacodylate buffer for 2 hours. After postfixation in 0.2% OSO4 for 1 hour, muscles were treated with 0.2% tannic acid in 0.1 M cacodylate buffer for 20 minutes. The specimens were then stained en bloc with 1% uranyl acetate in water for 1 hour, dehydrated, and embedded in Epon. Thin sections were stained with uranyl acetate and lead citrate and examined in a transmission electron microscope (model 100-B, JEOL EUROPE, Schiphol-Oost, The Netherlands). For scanning electron microscopy, papillary muscles were fixed in the organ baths with 1% glutaraldehyde in 0. cacodylate buffer for 60 minutes. Muscles were then removed from the organ bath and further fixed for at least 1 hour. Specimens were postfixed with 0.2% osmium tetroxide in cacodylate buffer, dehydrated through a graded acetone series, and criticalpoint-dried with CO2 as the transition fluid in a Balzer's apparatus. The dried muscles were coated with a 15-nm-thick layer of gold using a Balzer's sputtering device. The papillary muscles were examined in a scanning electron microscope (model AMR-1200-B, E. Leitz, Wetzlar, FRG).
Drugs
The effects of 0.1 nM to 1 ,uM Ang I (Sigma Chemical, St. Louis, Missouri) and 0.1 nM to 0.1 ,M Ang II (Sigma Chemical) were studied in muscles with intact EE and in the same group of muscles after damaging the EE. Captopril (0.1-10 ,uM) (E.R. Squibb & Sons, Princeton, New Jersey) was used as an ACE inhibitor. The effects of captopril on the responses to Ang I and Ang II were studied in separate groups of muscles with intact and with damaged EE. Indomethacin (10 ,M) (Sigma Chemical) was used for cyclooxygenase inhibition. Propranolol (1 ,M) (Sigma Chemical) and prazosin (10 ,M) (Pfizer Laboratories, New York, New York) were used for pand a,-blockade, respectively. All drugs were dissolved in distilled water, and aliquots were added to the organ bath; adding the same amount of distilled water to the bathing solution had no effect on the muscle. Measurements were made after stabilization of the twitches. Statistical analysis of the experimental data was obtained by Student's paired t test. (EE) . Mean values (+SEM) are shown for total peak isometric twitch tension (TT), time to half isometric twitch tension decline (RTI2), and maximum velocity of unloaded shortening (Vm,). B, baseline values; TR, after 0.5% Triton treatment for 1 second; l,,, muscle length at which active force development was maximal. *p<0.05, **p<0.01, and ***p<0.001 denote statistically significant differences compared with baseline values before angiotensin addition.
Results
Response to Ang I and II in Intact Muscles
In a dose-dependent manner, Ang I (between 0.1 nM and 1 ,uM) induced an increase in peak isometric twitch tension (IT) with slight twitch prolongation (Figures 2-4) . The slight prolongation of the twitches, as derived from measurements of the time from the stimulus to half isometric tension decline in the isometric twitch (RT/2), was a consistent observation in most muscles and significant for the group of muscles as a whole. The increase in Vmax was also significant (Figures 3 and 4) .
In a dose-dependent manner, Ang II (between 0.1 nM and 0.1 ,uM) also caused a similar pattern of positive inotropic response. Ang I and Ang II were equipotent in increasing inotropism around the threshold of 0.1 nM. However, at higher concentrations of angiotensin, doses of Ang I about 10 times greater than Ang II were required for the same inotropic effect. In contrast to observations by others,3 steady inotropic responses to Ang I and Ang II in the present study were established rapidly (usually within 2 minutes) and could be reversed by replacing the bathing solution with fresh physiological solution.
In a separate group of intact muscles under combined al-and 8-blockade with 10 ,uM prazosin and 1 ,tM propranolol, respectively ( Figure 5 ), the inotropic response to Ang II was not significantly different from the response in the intact control muscles (Figures 3 and 4 ).
Response to Ang I and II in Muscles With
Damaged EE Damaging the EE by brief (1-second) Triton exposure (Figure 1 ) decreased Ti and RT/2, without significantly affecting Vmax. Figure 3 shows the absolute values of TT, RT/2, and Vm,,, of the baseline twitches before and after Triton damage to the EE for both groups of muscles. Damaging the EE had no effect on the inotropic responses to either Ang I or Ang II (Figure 3) ; thus, the presence of an intact EE was not a prerequisite for the positive inotropic action of Ang I and Ang II. The absence of a significant role of the EE can be better appreciated by referring to Figure 4 , in which the data from Figure 3 were replotted as a percentage of the baseline values. The slight separation between the two Ang II response curves (Figure 4 , upper right panel) was not significant.
Even when, as in the separate group of muscles in Figure 6 , appropriate amounts of Ca2' were added first to correct for the different inotropic starting conditions after Triton treatment, the subsequent responses to Ang I and II were not significantly different from the responses in the intact control muscles.
Influences of ACE Inhibition
In separate groups of muscles with intact and with damaged EE, the effects of Ang I and Ang II were studied in the presence of an ACE inhibitor, captopril (Figures 7 and 8 ). The addition of captopril itself had no significant effect on the baseline performance of these muscles.
Both in the presence and absence of an intact EE, the positive inotropic response to Ang I, but not to Ang II, was abolished by 0.1-10 ,M captopril in a dose-dependent manner (Figure 7) , indicating that the positive inotropic response to Ang I could be attributed entirely to an Ang II effect.
The responses to Ang I and Ang II at the highest concentration of captopril (10 ,uM) were compared in Figure 8 . Notice that the TT response to Ang II in the presence of damaged EE (Figure 8 , right panel) started from a significantly lower value than in the presence of an intact EE (Figure 8 , left panel) but increased more steeply and attained higher values at and beyond 0.01 ,uM Ang II. The difference between these two dose-response curves to Ang II under captopril in the presence and absence of an intact EE was more striking still when the data from Figure 8 were normalized as in Figure 9 and compared with the control Ang II dose-response curve from Figure 4 in the absence of captopril and with intact EE (Figure 4, upper right panel) . When compared with this latter control curve, the addition of 10 ,uM captopril significantly diminished the inotropic response to Ang II when the EE was intact but significantly potentiated the response to Ang II when the EE was damaged. Note that this captoprilinduced and EE-mediated modulation was also observed for the response to Ang I at the lowest concentrations of captopril (Figure 7 , left panel).
Influence of Cyclooxygenase Inhibition
From the above phenomenon, it was clear that the captopril-induced and EE-mediated modulation of the angiotensin response was equally significant both at a low concentration of captopril (0.1 ,uM), in which the response to Ang I was only slightly suppressed (Figure 7, left panel) , and at the higher concentration of captopril (10 ,uM) , in which the response to Ang I was fully abolished (Figure 9 ). These data indicate that the above phenomenon necessitated very low concentrations of captopril and that it could be ascribed to actions of captopril other than through ACE inhibition.
The addition of 10 ,uM indomethacin, an inhibitor of cyclooxygenase, completely abolished the above phenomenon (Figure 9 ). The responses to Ang II under combined captopril and indomethacin, both in the presence and absence of an intact EE, were indeed not significantly different from the control Ang II response curve with intact EE and with no additional drugs. Damage of the Endocardial Endothelium by Angiotensin Figure 10 illustrates that prolonged exposure (30 minutes) to Ang I and Ang II selectively damaged the EE without impairment of the subjacent myocar- dium. EE damage was consistently observed at and beyond 1.0 ,uM Ang I (n=5) and 0.1 ,uM Ang II (n=21). These muscles were not included in Table 1 .
The slightly diminished TT response to high concentrations of Ang 1 (1.0 ,uM) and Ang 11 (0.1 ,uM) in the intact muscles of Figures 4, 5, and 6, along with the concomitant slight decline of RT/2, could also be consistent with some EE damage33 at these higher angiotensin concentrations.
Discussion
The present study demonstrates that 1) the positive inotropic effect of Ang I did not necessitate the presence of an intact EE, 2) the response to Ang I was abolished after addition of ACE inhibitor captopril, 3) a modulatory effect of the EE on the inotropic response to Ang II was revealed after addition of captopril, 4) this latter modulation was blocked by 
Presence ofACE
The suppression by captopril of the response to Ang I and not to Ang II confirmed that ACE activity is present in cardiac tissue42,43 and that the positive inotropic response to Ang I could be attributed entirely to an Ang II effect. These results were in contrast with Trachte and Lefer,44 who found no significant altered response to Ang I in the presence of captopril. Because the response to Ang I did not necessitate the presence of an intact EE, our data indicated that, even assuming that some ACE activity would be present in the EE,38 a sufficient amount of ACE was present outside the EE. Hence, the exact site in the heart where either local or systemic Ang I is converted into Ang II remains uncertain; myocytes as well as nonmyocytes may participate. Inotropic Response Although the positive inotropic effects of Ang II are well established, the underlying mechanisms are only partially understood. Specific high affinity receptors for Ang II have been demonstrated on cultured neonatal rat heart myocytes,14,45 on sarcolemmal membranes from bovine and rabbit ventricle, 13"15,16 and in the conduction system of rat hearts.38 However, the absence of a positive inotropic effect in some species, such as the guinea pig and rat, cannot easily be explained. Despite the presence of receptors on rat myocytes,14'45 a positive inotropic response could not be demonstrated.7,30 Studies on dog papillary muscles have indicated that the positive inotropic effect may be indirect and may result from the release of catecholamines from cardiac stores.2 However, in cat papillary muscle' and in isolated perfused cat heart,3 the inotropic action of angiotensin was not blocked by ,3-receptor antagonists3 or by prior treatment with reserpine.3 Moreover, from the present study, 18or a,-agonist activity of catecholamines are not likely to be involved as primary mechanisms of the inotropic response to Ang II. Other studies in different preparations have shown that the action of Ang II may be exerted through activation of the voltage-sensitive slow calcium channels.56'1745'46 A calcium-related mechanism was supported further in the present study by the observation that aftercontractions often occurred at the highest concentrations of angiotensin. It is not clear whether the change in Ca21 influx is a consequence of phosphatidylinositol diphosphate hydrolysis or is an independent effect of angiotensin-receptor interaction.
Although an increased phosphoinositide hydrolysis could be involved,7,45'4748 phosphoinositide turnover was recently shown not to directly couple to the inotropic mechanism.7
Captopnl-Induced EE-Mediated Modulation of Inotropic Response to Angiotensin
The role of prostaglandins is depicted in Figure 11 . Most interesting is the sensitization and desensitization of the angiotensin response by captopril in the absence and in the presence of an intact EE, respectively. These results are intriguing, yet very difficult to interpret at present. The effects were observed already at low concentrations of captopril and were unrelated to its inhibitory effect on the conversion of Ang I to Ang II. Other possible mechanisms could be a captopril-induced diminished breakdown of bradykinin or an increased prostaglandin production. Activation of prostaglandins was supported by the observation that the captopril-induced sensitization and desensitization were both equally abolished by indomethacin, a blocker of the arachidonic acid cascade. Further investigation is needed to determine the exact mechanism of such a captopril-revealed prostaglandin-angiotensin interaction and to what extent a captopril-induced diminished breakdown of bradykinin or of other tachykinins (e.g., substance P) would either directly or indirectly participate in these responses. With respect to the captopril-induced desensitization of the Ang II response in the presence of an intact EE, one could perhaps postulate that it is mediated through prostaglandin '2 released from the endothelial cells of the endocardium. Synthesis of prostacyclin is indeed considerable in human cardiac tissue, and the activity of tissue cyclooxygenase was found to be twice as high in the endocardium and located specifically in the endothelium. 49 On the other hand, the prostaglandin sensitization of the Ang II response under captopril in the absence of EE is at present unclear. Moreover, previous work from our laboratory5'} has demonstrated that neither prostaglandin 12 nor prostaglandin E2 has any direct effect on the basic contractile performance of isolated cardiac muscle.
The possible role of the prostaglandins in the captopril-induced EE-mediated desensitization of the inotropic response to Ang II, as well as the captopril-induced sensitization of this response in the presence of damaged EE, is an intriguing observation that needs additional studies. To exclude some idiosyncratic, nonspecific effect of captopril, the experiments should be duplicated with other ACE inhibitors. FIGURE 10. Scanning electron microscopy of endocardial endothelium on a papillary muscle exposed to 0.1 gM angiotensin I. figure) on myocardium (data from Figure 4 ). -EE, absence of intact EE; TT, total peak isometric twitch tension. Panel B: The presence of an intact EE (+EE) does not significantly affect the inotropic response to angiotensin (data from Figure 4 ). Panel C: Sensitization by CAPT of angiotensin response in the absence of EE. Panel D: Desensitization by CAPT of angiotensin response in the presence of EE. Both sensitization (panel C) and desensitization (panelD) were equally abolished by indomethacin (data from Figure 9 ). Moreover, some other specific effects of indomethacin, such as its influence on lipoxygenase-dependent products or on platelet-activating factor, as well as its nonspecific modulation of cyclic AMP and phosphodiesterase, should also be considered. In addition, clinical studies in humans are needed for the therapeutic implications. The pathophysiological implications of EE damage induced by high concentrations of angiotensin in the pathogenesis of various cardiac diseases, particularly with respect to protection by ACE inhibitors against such EE damage, also need further investigation.
